ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment of Patients With Cysticercosis With Praziquantel or Albendazole

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00001205
Recruitment Status : Recruiting
First Posted : November 4, 1999
Last Update Posted : May 14, 2018
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Allergy and Infectious Diseases (NIAID) )